Table.1 Baseline characteristics: CSF examination (n = 10) and other diagnostic findings
From: Neurological management and work-up of neurotoxicity associated with CAR T cell therapy
Diagnostic methods | Patients (n) | |
|---|---|---|
Signs and/or symptoms of neuropathy | Clinical | 11/15 |
Neurography | 15/15 | |
Brain MRI | Vascular lesions (Fazekas grade ≥ 2) | 2/15 |
EEG | Subtle vigilance fluctuations | 6/15 |
CSF analysis | Elevated cell count | 0/10 |
Elevated protein | 2/10 | |
Elevated Qalbumin | 2/10 | |
Oligoclonal bands | 0/10 | |